P-56 EXPERIENCE WITH DEXMEDETOMIDINE IN THE MANAGEMENT OF ALCOHOL WITHDRAWAL SYNDROME FOR PATIENTS WITH CIRRHOSIS
Conflict of interest: No Introduction and Objectives: Lorazepam is the first-line treatment in patients with alcohol withdrawal syndrome (AWS). In patients with cirrhosis and AWS, the use of dexmedetomidine (DXM) has been poorly studied. The objective of this study is to report the effect of DXM in...
Saved in:
| Main Authors: | Liliana Ivonne Gallardo Gonzalez, Jose Luis Perez Hernandez, Maria Fatima Higuera de la Tijera |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Annals of Hepatology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268124004538 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experience with dexmetomidine in the management of alcohol withdrawal syndrome for patients with cirrhosis
by: Liliana I. Gallardo-González, et al.
Published: (2025-04-01) -
Participation of the immune response and oxidative stress in alcoholism and liver cirrhosis due to alcohol
by: Leonardo S. Juárez-Chávez, et al.
Published: (2025-04-01) -
P-125 FACTORS ASSOCIATED WITH THE DEVELOPMENT OF POST-BANDING ULCER BLEEDING IN PATIENTS WITH CIRRHOSIS.
by: Sandra Teutli Carrión, et al.
Published: (2024-12-01) -
Comparing clonidine and dexmedetomidine effects in the treatment of opiate withdrawal syndrome in poisoned patients
by: Azadeh Memarian, et al.
Published: (2024-10-01) -
Adrenergic Inhibition with Dexmedetomidine to Treat Stress Cardiomyopathy during Alcohol Withdrawal: A Case Report and Literature Review
by: Zachary M. Harris, et al.
Published: (2016-01-01)